Vitalii Usenko

Medical Director, Farmak (Ukraine)

Adrian Otte

Independent Consultant; formerly Vice-President Amgen, Senior Vice-President Pfizer (USA)

Ulrike M. Grimm

Head Global Project & Alliance Management, Vice President, Vifor Pharma

Julian V. Platon

Clinical & Medical Head EU, Luye Pharma (Switzerland)

Martine Dehlinger-Kremer

President of EUCROF; VP Pediatric Development Synteract (Germany)

Jeffrey Apter

President of Global Clinical Trials LLC (USA)

Alexander GISSLER

Chief Executive Officer, ProjectPharm (Czech Republic)

Faidra van der Wal

Global Trial Manager, Janssen Pharmaceuticals (Netherlands)

Vivienne van de Walle

Owner, Independent research site PT&R (Netherlands)

Riccardo Belli

Director, Novartis Oncology (Switzerland)

Donato Bonifazi

CEO, Consorzio per Valutazioni Biologiche e Farmacologiche (Italy)

Piotr Wlodarczyk

Abi Vainstein-Haras

Vice President Clinical and Medical Affairs, BioLineRx (Israel)

Irit Gliko Kabir

Senior Director Clinical Operations at BioLineRx (Israel)

Michele Garot

Managing Director and Owner of CLINCellence (Belgium)

Ivana Haluskova Balter (France)

Independent consultant science and research for global health

Rino Coladangelo

CEO of Rephine Ltd (UK)

Wojciech Smoron

Global Trial Director, Novartis (Switzerland)

Janusz Kabata

Janusz Kabata, CEO, GP4Research (Poland)

Prof. Igor Bondarenko

Head of Department of Oncology, Dnipropetrovsk Medical Academy (Ukraine)

Elizabeth Tarshish

Head of Clinical Affairs, Lycored (Israel)

Stanislav Praslov

Clinical Research Consultant (Russia)

Cesare Spadoni

Chairman, aPODD Fundation (UK)

Dmitry Semenyuta

Country Manager, PPD (Ukraine)